GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

microtubule associated protein tau   Click here for help

GtoPdb Ligand ID: 9275

Compound class: Endogenous peptide in human, mouse or rat
Comment: The MAPT gene transcript undergoes complex, regulated alternative splicing. Different splice variants are expressed in different neurons and at different stages of neuronal maturation. The 757 amino acid isoform 1 contains three tau/MAP repeats which mediate tau interaction with tubulin (isoforms with four tau/MAP repeats are also reported).

MAPT gene polymorphisms are reported to predispose to neurodegenerative diseases including Alzheimer's disease (AD), Pick's disease [3-4,7] and frontotemporal dementia [5-6,12]. These types of conditions are known as tauopathies. The neurofibrillary tangles detected in AD brains are made up of pathologic paired helical filaments composed in large part of a truncated 100-amino-acid fragment of tau protein [11].

So far we have annotated three types of target relationships for tau protein:
1) aggregation antagonists/inhibitors (e.g. leucomethylthioninium)
2) imaging reagents for detection (e.g. flortaucipir (18F))
3) anti-tau monoclonal antibodies (e.g. zagotenemab)

In addition to zagotenemab, other clinical stage mAbs that target tau include gosuranemab (BMS-986168/BIIB092; for progressive supranuclear palsy PSP- development terminated, primary endpoint was not met in Phase 2), semorinemab (RO-7105705; for AD), tilavonemab (ABBV-8E12; for PSP and AD) and bepranemab (UCB0107; originally in development for PSP).
Species: Human
Other ligands which bind to or alter the activity of this ligand
Key to terms and symbols Click column headers to sort
Ligand Sp. Type Action Value Parameter Concentration range (M) Reference
posdinemab Peptide Hs Antibody Binding >10.5 pKd - 10
⤷ pKd >10.5 (Kd <3x10-11 M) [10]
Description: Binding affinity for phospho-Tau (pT212/T217) paired helical filaments determined by SPR
zagotenemab Peptide Hs Antibody Binding 9.7 pKd - 1
⤷ pKd 9.7 (Kd 2.2x10-10 M) [1]
Description: Binding affinity for soluble tau aggregate by surface plasmon resonance (SPR).
QC-01-175 Small molecule or natural product Hs None Binding:
PROTAC degrader		 5.9 pKd - 9
⤷ pKd 5.9 (Kd 1.2x10-6 M) PROTAC degrader [9]
Description: In vitro binding affinity for wild-type human tau determined using a biolayer interferometry (BLI) assay.
PROTAC T3 Small molecule or natural product Hs None Binding:
PROTAC degrader		 5.6 pKd -
⤷ pKd 5.6 (Kd 2.78x10-6 M) PROTAC degrader
flortaucipir (18F) Small molecule or natural product Approved drug Ligand is labelled Ligand is radioactive Hs None Binding - - - 8
⤷ [8]
leucomethylthioninium Small molecule or natural product Approved drug Hs Inhibitor Binding - - - 2
⤷ [2]